CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Our technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Our miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Nanotextiles and Personal Care
We at BioCure are committed to be a leading company in the dynamic healthcare market.
We are dedicated to serve the medical community and the patients under their care by providing product solutions to treat many medical conditions where today's therapies are either deficient or non-existent.
Our vision is to create strong, product-focused collaborations with leading commercialization partners in the fields of medical devices and biotechnology.
The Sanofi Pasteur VaxDesign Campus designs, develops, and manufactures in vitro models of the human immune system. Our mission is to prevent infectious disease by forecasting vaccine responses before clinical trials, and create a competitive advantage by providing predictive in vitro immunological models and assays.
TGN’s business strategy involves both short- and long-term objectives that will generate revenue in the present and facilitate future R & D. TGN continues to generate revenue from the sales of custom nanoparticles and Nanogene™ reagents and Federal and State grant-funding mechanisms for small businesses to support R & D. TGN plans to develop and market diagnostic reagents/kits for the detection of viral infections, including AIDS, and the early detection of cancers.
Radiation Shield Technologies (RST) is the world leader in the research, design and production of personal protection systems for ionizing and nuclear radiation. The company's core technology, Demron™ , is specifically engineered to combine radiation protection with "ease of use" in order to maximize effective radiological defense.
Since 1992, Ocean Optics has been developing and manufacturing the highest quality, most innovative products for optical sensing and more. Our spectrometers and complementary technologies have traveled to the Moon, inside active volcanoes, through rain forests and to the top of Mount Everest. Finding your answer begins with Ocean Optics.
Continental Carbon Company's recent developments in flame and catalyst technology are leading to a new product line of multiwall carbon nanotubes (MWNTs). CCC's unique, metal-free catalyst synthesis offers a continuous process for the commercial production of high quality multiwall carbon nanotubes. CCC's mission is to be a quality conscious, ethical, and preferred developer, manufacturer, and marketer of carbon products.
Natural-Immunogenics has a special responsibility... to bring its new generation of colloids [appropriately called "hydrosols"] to those who need it for their own health, as well as to those who attend upon the health of others.
Sovereign Silver® represents the most significant breakthrough in colloidal technology in the last 90 years. It is an omnipotent resource in the defense of health, one with which to confront the ever increasing immune challenges threatening man, even the whole of mankind.
Nanotherapeutics has significant expertise in product formulation, pre-clinical and clinical development, scale-up and cGMP manufacturing, utilizing established and proprietary techniques: NanoQUAD™, NanoDRY™, and NanoCOAT™. Our specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements and fewer side effects.